HCA Holdings (HCA) PT Raised to $310 at Jefferies

Jefferies analyst Brian Tanquilut raised the price target on HCA Holdings (NYSE: HCA) to $310.00 (from $290.00) while maintaining a Buy rating, noting while FY22 guidance is a near-term focus execution is still core to the story.

The analyst commented, "We maintain our Buy on HCA given our belief that its continued execution success -- in areas such as CapEx investments, market expansions (new and existing) through M&A, service line extensions, and payor relations -- will translate to sustained healthy growth, cash flow generation, and stock upside. So while NT COVID noise exists -- and investors are focused on FY22 guidance given COVID and labor concerns -- HCA's core investment story remains compelling."

You May Also Be Interested In

• Fiserv (FISV) PT Lowered to $60 at Freedom Broker
• Indigo Paints (INDIGOPN:IN) PT Raised to INR1,300 at ICICI Securities
• Freedom Broker Upgrades Serve Robotics (SERV) to Buy